Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Suzanne McCluskey, M.D.

Concepts (89)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Drug Resistance, Viral920248661.620 Why?
Oxazines520243581.530 Why?
HIV Integrase Inhibitors420241641.530 Why?
Anti-HIV Agents13202445581.490 Why?
HIV Infections192024175311.350 Why?
Viral Load8202433851.310 Why?
Pyridones520248161.230 Why?
Heterocyclic Compounds, 3-Ring520242951.200 Why?
Piperazines5202425460.860 Why?
HIV-18202469440.820 Why?
HIV Integrase120211210.680 Why?
Anti-Retroviral Agents5202317860.620 Why?
Viremia220217270.610 Why?
Uganda7202413530.610 Why?
Antiretroviral Therapy, Highly Active4202118990.560 Why?
Lamivudine420243680.520 Why?
HIV2202315850.420 Why?
Rural Population2201823170.350 Why?
Treatment Failure4202426530.320 Why?
Disease Management1201925340.300 Why?
World Health Organization2202313270.230 Why?
Africa South of the Sahara320217510.210 Why?
Anthozoa12021650.180 Why?
Opportunistic Infections120233760.170 Why?
South Africa5202418670.170 Why?
Patient Isolation120201010.170 Why?
Point-of-Care Systems2202412170.140 Why?
Hepacivirus1202413430.140 Why?
Dideoxynucleosides120171350.140 Why?
Counseling1202415510.130 Why?
Hepatitis C, Chronic1202410320.130 Why?
Models, Economic120207160.120 Why?
Reverse Transcriptase Inhibitors120176180.110 Why?
Weight Gain1202423550.110 Why?
Humans2420247657340.110 Why?
Medication Adherence1202421900.100 Why?
Antiviral Agents1202430520.100 Why?
Longitudinal Studies22018147450.090 Why?
Adult1020242229740.090 Why?
Microbial Sensitivity Tests1201719710.090 Why?
Cost-Benefit Analysis2202055260.080 Why?
Prevalence32024158330.080 Why?
RNA, Viral1201728650.080 Why?
Prospective Studies32024547950.080 Why?
Nucleic Acid Amplification Techniques220213350.080 Why?
Mutation32024301840.070 Why?
Clinical Clerkship120135680.070 Why?
Treatment Outcome32024651800.060 Why?
Internal Medicine1201310640.060 Why?
Drug Resistance2202215910.060 Why?
Retrospective Studies32023814570.060 Why?
Sex Factors12018106050.060 Why?
Female1020243959610.060 Why?
Lung12022100310.050 Why?
CD4 Lymphocyte Count2202125860.050 Why?
Male820243635850.050 Why?
Drug Substitution120242920.050 Why?
Young Adult22024598520.040 Why?
Alkynes120213260.040 Why?
Cyclopropanes120214370.040 Why?
Benzoxazines120213200.040 Why?
Cohort Studies22018416310.040 Why?
Lung Neoplasms12022134480.040 Why?
Middle Aged420242229030.040 Why?
Quality of Life32023134620.030 Why?
HLA-B Antigens120173290.030 Why?
Communicable Disease Control120208560.030 Why?
Alabama120131110.030 Why?
Social Welfare12013860.020 Why?
Lung Diseases1202219400.020 Why?
United States12019728980.020 Why?
Genotype12024130240.020 Why?
Academic Medical Centers1202027790.020 Why?
Odds Ratio1202196470.020 Why?
Boston1202093370.020 Why?
CD4-Positive T-Lymphocytes1202044050.020 Why?
Teaching1201311700.020 Why?
Health Promotion1201722080.020 Why?
Pilot Projects1201787320.010 Why?
Cross-Sectional Studies12024262840.010 Why?
Research Design1201762070.010 Why?
Hospitalization12020108060.010 Why?
Randomized Controlled Trials as Topic12017103850.010 Why?
Tomography, X-Ray Computed12022206670.010 Why?
Time Factors12020400660.010 Why?
Clinical Competence1201348620.010 Why?
Follow-Up Studies12017391800.010 Why?
Pregnancy12017302480.010 Why?
Animals120211687310.010 Why?
McCluskey's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (89)
Explore
_
Co-Authors (38)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.